Source:http://linkedlifedata.com/resource/pubmed/id/19690170
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
42
|
pubmed:dateCreated |
2009-10-12
|
pubmed:abstractText |
CCAAT/enhancer-binding Protein beta (C/EBPbeta) is a member of the bZIP transcription factor family that is expressed in various tissues, including cells of the hematopoietic system. C/EBPbeta is involved in tissue-specific gene expression and thereby takes part in fundamental cellular processes such as proliferation and differentiation. Here, we show that the activity of C/EBPbeta is negatively regulated by the transcriptional co-repressor Daxx. C/EBPbeta was found to directly interact with Daxx after overexpression as well as on the endogenous level. Glutathione S-transferase pulldown assays showed that Daxx binds via amino acids 190-400 to the C-terminal part of C/EBPbeta. Co-expression of C/EBPbeta changed the sub-nuclear Daxx distribution pattern from predominantly POD-localized to nucleoplasmic. Daxx suppressed basal and p300-enhanced transcriptional activity of C/EBPbeta. Furthermore, Daxx decreased the C/EBPbeta-dependent phosphorylation of p300, which in turn was associated with a diminished level of p300-mediated C/EBPbeta acetylation. Co-expression of promyelocytic leukemia protein abrogated the repressive effect of Daxx on C/EBPbeta as well as the direct interaction of Daxx and C/EBPbeta, presumably by re-recruiting Daxx to PML-oncogenic domains. In acute promyelocytic leukemia (APL) cells, C/EBPbeta activity is known to be required for all-trans-retinoic acid-induced cell differentiation and disease remission. We show that all-trans-retinoic acid as well as arsenic trioxide treatment leads to a reduced C/EBPbeta fraction associated with Daxx suggesting a relief of Daxx-dependent C/EBPbeta repression as an important molecular event leading to APL cell differentiation. Overall, our data identify Daxx as a new negative regulator of C/EBPbeta and provide first clues for a link between abrogation of Daxx-C/EBPbeta complex formation and APL remission.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adaptor Proteins, Signal Transducing,
http://linkedlifedata.com/resource/pubmed/chemical/CCAAT-Enhancer-Binding Protein-beta,
http://linkedlifedata.com/resource/pubmed/chemical/DAXX protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Nuclear Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Tretinoin,
http://linkedlifedata.com/resource/pubmed/chemical/p300-CBP Transcription Factors
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1083-351X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
16
|
pubmed:volume |
284
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
28783-94
|
pubmed:dateRevised |
2010-10-19
|
pubmed:meshHeading |
pubmed-meshheading:19690170-Adaptor Proteins, Signal Transducing,
pubmed-meshheading:19690170-Animals,
pubmed-meshheading:19690170-CCAAT-Enhancer-Binding Protein-beta,
pubmed-meshheading:19690170-Cell Differentiation,
pubmed-meshheading:19690170-Fibroblasts,
pubmed-meshheading:19690170-Gene Expression Regulation,
pubmed-meshheading:19690170-Gene Expression Regulation, Leukemic,
pubmed-meshheading:19690170-HeLa Cells,
pubmed-meshheading:19690170-Humans,
pubmed-meshheading:19690170-Leukemia, Promyelocytic, Acute,
pubmed-meshheading:19690170-Nuclear Proteins,
pubmed-meshheading:19690170-Phosphorylation,
pubmed-meshheading:19690170-Protein Structure, Tertiary,
pubmed-meshheading:19690170-Quail,
pubmed-meshheading:19690170-Tretinoin,
pubmed-meshheading:19690170-p300-CBP Transcription Factors
|
pubmed:year |
2009
|
pubmed:articleTitle |
Daxx is a transcriptional repressor of CCAAT/enhancer-binding protein beta.
|
pubmed:affiliation |
Institut für Biochemie, Westfälische-Wilhelms-Universität Münster, Wilhelm-Klemm-Strasse 2, Münster D-48149, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|